报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 5.77% | 47.19% | 79.19% | 62/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 3.22% | -34.15% | 67.71% | 61/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 1.92% | -9% | -44.83% | 62/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 3.48% | -48.6% | -11.22% | 76/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 3.92% | -52.66% | -19.84% | 82/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 4.89% | 58.77% | 131.75% | 44/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 2.11% | 31.88% | -68.83% | 60/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 6.77% | -50.44% | -18.24% | 60/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 8.28% | -18.5% | 168.83% | 44/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 3.08% | -45.68% | 92.5% | 67/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 1.6% | -17.53% | -88.29% | 71/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 13.66% | -53.24% | 34.45% | 27/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 10.16% | -41.37% | 79.19% | 32/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 5.67% | -44.25% | 192.27% | 45/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 1.94% | 2% | -93.36% | 69/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 29.21% | 1.78% | 68.55% | 5/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | 17.33% | 2% | 70.4% | 11/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-06-30 | 10.17% | 2% | -64.56% | 18/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
2019-12-31 | 28.7% | 2% | 2% | 5/160 | 2.78% | 汇宇制药 | 31.9% | 行业排名> |